相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pertuzumab in Combination with Trastuzumab Shows Significantly Enhanced Antitumor Activity in HER2-Positive Human Gastric Cancer Xenograft Models
Yoriko Yamashita-Kashima et al.
CLINICAL CANCER RESEARCH (2011)
A Novel Anti-CEACAM5 Monoclonal Antibody, CC4, Suppresses Colorectal Tumor Growth and Enhances NK Cells-Mediated Tumor Immunity
Chaogu Zheng et al.
PLOS ONE (2011)
Prospective Evaluation of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 15.3 (CA 15.3) in Patients with Primary Locoregional Breast Cancer
Rafael Molina et al.
CLINICAL CHEMISTRY (2010)
Metastatic breast tumors express increased tau, which promotes microtentacle formation and the reattachment of detached breast tumor cells
M. A. Matrone et al.
ONCOGENE (2010)
Deregulation of the CEACAM Expression Pattern Causes Undifferentiated Cell Growth in Human Lung Adenocarcinoma Cells
Bernhard B. Singer et al.
PLOS ONE (2010)
Harnessing the unique local immunostimulatory properties of modified vaccinia Ankara (MVA) virus to generate superior tumor-specific immune responses and antitumor activity in a diversified prime and boost vaccine regimen
James W. Hodge et al.
VACCINE (2009)
Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines
Michael A. Morse et al.
BLOOD (2008)
Therapy of advanced established murine breast cancer with a recombinant adenoviral ErbB-2/neu vaccine
Jong Myun Park et al.
CANCER RESEARCH (2008)
Balancing between Antitumor Efficacy and Autoimmune Pathology in T-Cell-Mediated Targeting of Carcinoembryonic Antigen
Rinke Bos et al.
CANCER RESEARCH (2008)
Co-administration of carcinoembryonic antigen and HIV TAT fusion protein with CpG-oligodeoxynucleotide induces potent antitumor immunity
Sun-Je Woo et al.
CANCER SCIENCE (2008)
Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma
James L. Gulley et al.
CLINICAL CANCER RESEARCH (2008)
Accessing the therapeutic potential of immunostimulatory nucleic acids
Winfried Barchet et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer
Shengming Dai et al.
MOLECULAR THERAPY (2008)
The human carcinoembryonic antigen (CEA) GPI anchor mediates anoikis inhibition by inactivation of the intrinsic death pathway
P. Camacho-Leal et al.
ONCOGENE (2008)
Mucosal delivery of a transmission-blocking DNA vaccine encoding Giardia lamblia CWP2 by Salmonella typhimurium bactofection vehicle
Aws Abdul-Wahid et al.
VACCINE (2007)
O-glycosylated human MUC1 repeats are processed in vitro by immunoproteasomes
Tanja Ninkovic et al.
JOURNAL OF IMMUNOLOGY (2007)
Carcinoembryonic antigen inhibits anoikis in colorectal carcinoma cells by interfering with Trail-R2 (DR5) signaling
Raed N. Samara et al.
CANCER RESEARCH (2007)
Breast cancer vaccines: a clinical reality or fairy tale?
G Curigliano et al.
ANNALS OF ONCOLOGY (2006)
Identification of novel subdominant epitopes on the carcinoembryonic antigen recognized by CD4+ T cells of lung cancer patients
Mariacristina Crosti et al.
JOURNAL OF IMMUNOLOGY (2006)
Characterization of gastric adenocarcinoma cell lines established from CEA424/SV40 T antigen-transgenic mice with or without a human CEA transgene -: art. no. 57
J Nöckel et al.
BMC CANCER (2006)
Serum tumor markers in breast cancer: Are they of clinical value?
MJ Duffy
CLINICAL CHEMISTRY (2006)
Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma
SA Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2005)
Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic antigen)
RD Blumenthal et al.
CANCER RESEARCH (2005)
Tumor markers in breast cancer - European Group on Tumor Markers recommendations
R Molina et al.
TUMOR BIOLOGY (2005)
Modulation of the Leishmania donovani peroxin 5 quaternary structure by peroxisomal targeting signal 1 ligands
KP Madrid et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Enhancement of cytotoxic T-lymphocyte responses in patients with gastrointestinal malignancies following vaccination with CEA peptide-pulsed dendritic cells
K Matsuda et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Identification of a MHC class-II restricted epitope in carcinoembryonic antigen
L Shen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Carcinoembryonic antigen as a target for therapeutic anticancer vaccines: A review
NL Berinstein
JOURNAL OF CLINICAL ONCOLOGY (2002)
Preoperative values of CA 15-3 and CEA as prognostic factors in breast cancer:: A multivariate analysis
F Cañizares et al.
TUMOR BIOLOGY (2001)
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: Clinical practice guidelines of the American Society of Clinical Oncology
RC Bast et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
